Conclusion

30 August 2024 (13:10 - 13:15)

Organised by:

Video

Sign in to view the resources

About the speakers

Associate Professor Marianna Adamo

Civil Hospital of Brescia, Brescia (Italy)

Professor Philipp Lurz

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

6 More presentations in this session

Presentation thumbnail

Introduction

Professor S. Windecker (Bern, CH) Professor M. Boehm (Homburg, DE)

Presentation thumbnail

Implication on how to best identify and treat HF patients with tricuspid regurgitation

Doctor A. Vazir (London, GB)

Presentation thumbnail

Con - transcatheter tricuspid valve therapies are NOT hot and will remain only a niche

Associate Professor M. Adamo (Brescia, IT)

Presentation thumbnail

Pro - transcatheter tricuspid valve therapies are HOT and are a foundation therapy for patients with HF and tricuspid regurgitation

Professor P. Lurz (Mainz, DE)

Presentation thumbnail

Update and current status on transcatheter therapies for tricuspid regurgitation

Doctor S. Zieroth (Winnipeg, CA)

Access the full session

Session thumbnail

Hot or not debate - transcatheter tricuspid interventions now and tomorrow

The Event

Event poster

ESC Congress 2024

30 August 2024 13:10 CET

You may be interested in

Congress Presentation

Hype, hope, and how to tell the difference in tricuspid regurgitation - discussion

11 December 2025

Congress Session

Cardiology Toolbox - Clinical trial design

31 August 2025

Congress Presentation

Highlights from Tri. fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

31 August 2024

Congress Presentation

What is the evidence for TEER in tricuspid regurgitation?

1 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources